Skin regenerative potentials of curcumin

BioFactors

Volumn 39, Issue 1, 2013, Pages 141-149

  Thangapazham, Rajesh L ^a   Sharad, Shashwat ^a   Maheshwari, Radha K ^b  

^a Uniformed Services University of the Health Sciences   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Anticancer; Chemoprevention; Curcumin; Skin regeneration; Wound healing

Indexed keywords

CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CHEMOPROPHYLAXIS; DETOXIFICATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; HUMAN; MELANOMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN CANCER; SKIN DISEASE; SKIN PROTECTION; SKIN REGENERATION; TISSUE REGENERATION; VITILIGO; WOUND HEALING;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTINEOPLASTIC AGENTS; CURCUMIN; DRUG DELIVERY SYSTEMS; HUMANS; RE-EPITHELIALIZATION; REGENERATION; SKIN; SKIN ABSORPTION; SKIN NEOPLASMS; WOUND HEALING;

CURCUMA LONGA;

EID: 84874110664     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1078     Document Type: Review

References (88)

1. Anand, P., Kunnumakkara, A. B., Newman, R. A., and Aggarwal, B. B. ( 2007) Bioavailability of curcumin: problems and promises. Mol. Pharm. 4, 807-818.
2. Thangapazham, R. L., Sharma, A., and Maheshwari, R. K. ( 2007) Beneficial role of curcumin in skin diseases. Adv. Exp. Med. Biol. 595, 343-357.
3. Basnet, P. and Skalko-Basnet, N. ( 2011) Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16, 4567-4598.
4. Thangapazham, R. L., Sharma, A., and Maheshwari, R. K. ( 2006) Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J. 8, 443-449.
5. Maheshwari, R. K., Singh, A. K., Gaddipati, J., and Srimal, R. C. ( 2006). Multiple biological activities of curcumin: a short review. Life Sci. 78, 2081-2087.
6. Kuttan, R., Sudheeran, P. C., Josph, C. D. ( 1987). Turmeric and curcumin as topical agents in cancer therapy. Tumori 73, 29-31.
7. Zhou, H., Beevers, C. S., and Huang, S. ( 2011) The targets of curcumin. Curr. Drug Targets 12, 332-347.
8. Tsai, K.-D., Lin, J.-C., Yang, S.-M., Tseng, M.-J., Hsu, J.-D., Lee, Y.-J., and Cherng, J.-M. ( 2012) Curcumin protects against UVB-induced skin cancers in SKH-1 hairless mouse: analysis of early molecular markers in carcinogenesis. Evid. Based Complement Alternat. Med. 2012, 593952.
9. Aggarwal, B. B., Surh, Y-J., and Shishodia, S., eds. ( 2007) The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Springer, Vol 495; 978-0-387-46401-5.
10. Kurd, S. K., Smith, N., VanVoorhees, A., Troxel, A. B., Badmaev, V., Seykora, J. T., and Gelfand, J. M. ( 2008) Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J. Am. Acad. Dermatol. 58, 625-631.
11. Aggarwal, B. B., Shishodia, S., Takada, Y., Jackson-Bernitsas, D., Ahn, K. S., Sethi, G., and Ichikawa, H. ( 2006) TNF blockade: an inflammatory issue. Ernst Schering Res. Found Workshop. 56, 161-186.
12. Rozieres, A., Hennino, A., and Nicolas, J. F. ( 2006) TNF alpha in the physiopathology of psoriasis. Ann. Dermatol. Venereol. 133, 174-180.
13. Schottelius, A. J. G., Moldawer, L. L., Dinarello, C. A., Asadullah, K., Sterry, W., and Edwards, C. K. ( 2004) Biology of tumor necrosis factor-alpha-implications for psoriasis. Exp. Dermatol. 13, 193-222.
14. Liu, Z. G. ( 2005) Molecular mechanism of TNF signaling and beyond. Cell Res. 15, 24-27.
15. Pierard-Franchimont, C. and Pierard, G. E. ( 2006) Etanercept (Enbrel) for the treatment of moderate to severe plaque type psoriasis. Rev. Med. Liege. 61, 201-205.
16. Cassano, N., Loconsole, F., Coviello, C., and Vena, G. A. ( 2006) Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int. J. Immunopathol. Pharmacol. 19, 237-240.
17. Santiskulvong, C., Sinnett-Smith, J., and Rozengurt, E. ( 2001) EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin. Am. J. Physiol. Cell. Physiol. 281, 886-898.
18. Wajant, H., Pfizenmaier, K., and Scheurich, P. ( 2003) Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65.
19. Islam, Z., Gray, J. S., and Pestka, J. J. ( 2006) p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes. Toxicol. Appl. Pharmacol. 213, 235-244.
20. Johansen, C., Funding, A. T., Otkjaer, K., Kragballe, K., Jensen, U. B., Madsen, M., Binderup, L., Skak-Nielsen, T., Fjording, M. S., and Iversen, L. ( 2006) Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J. Immunol. 176, 1431-1438.
21. Oz-Arslan, D., Ruscher, W., Myrtek, D., Ziemer, M., Jin, Y., Damaj, B. B., Sorichter, S., Idzko, M., Norgauer, J., and Maghazachi, A. A. ( 2006) IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids. J. Leukoc. Biol. 80, 287-297.
22. Sun, J., Han, J., Zhao, Y., Zhu, Q., and Hu, J. ( 2012) Curcumin induces apoptosis in tumor necrosis factor-alpha-treated HaCaT cells. Int. Immunopharmacol. 13, 170-174.
23. Grandjean-Laquerriere, A., Gangloff, S. C., Le Naour, R., Trentesaux, C., Hornebeck, W., and Guenounou, M. ( 2002) Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18, 168-177.
24. Shishodia, S., Sethi, G., and Aggarwal, B. B. ( 2005) Curcumin: getting back to the roots. Ann. N Y Acad. Sci. 1056, 206-217.
25. Han, S.-S., Keum, Y.-S., Seo, H.-J., and Surh, Y.-J. ( 2002) Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J. BiochemMolBiol. 35, 337-342.
26. Kang, G., Kong, P.-J., Yuh, Y.-J., Lim, S.-Y., Yim, S.-V., Chun, W., and Kim, S.-S. ( 2004) Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J. Pharmacol. Sci. 94, 325-328.
27. Leclercq, I. A., Farrell, G. C., Sempoux, C., dela Pena, A., and Horsmans, Y. ( 2004) Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J. Hepatol. 41, 926-934.
28. Cho, J.-W., Lee, K.-S., and Kim, C.-W. ( 2007) Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int. J. Mol. Med. 19, 469-474.
29. Hsu, Y. C., Chen, M. J., Yu, Y. M., Ko, S. Y., and Chang, C. C. ( 2010) Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch. Dermatol. Res. 302, 717-724.
30. Song, K., Peng, S., Sunm, Z., Li, H., and Yang, R. ( 2011) Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts. Biochem. Biophys. Res. Commun. 411, 821-825.
31. Lei, T. C., Vieira, W. D., and Hearing, V. J. ( 2002) In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by Photochemotherapy. Pigment Cell Res. 15, 426-432.
32. Schallreuter, K. U., Kruger, C., Wurfel, B. A., Panske, A., and Wood, J. M. ( 2008) From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int. J. Dermatol. 47, 743-753.
33. Spritz, R. A. ( 2008) The genetics of generalized vitiligo. Curr. Dir. Autoimmun. 10, 244-257.
34. Schallreuter, K. U., Wood, J. M., Lemke, K. R., and Levenig, C. ( 1995) Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 190, 223-229.
35. Schallreuter, K. U. and Rokos, H. ( 2006) Turmeric (curcumin): a widely used curry ingredient, can contribute to oxidative stress in Asian patients with acute vitiligo. Indian J. Dermatol. Venereol. Leprol. 72, 57-59.
36. Phan, T. T., See, P., Lee, S. T., and Chan, S. Y. ( 2001) Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J. Trauma. 51, 927-931.
37. Surh, Y. ( 1999) Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428, 305-327.
38. Surh, Y.-J. ( 2002) Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 40, 1091-1097.
39. Limtrakul, P., Lipigorngoson, S., Namwong, O., Apisariyakul, A., and Dunn, F. W. ( 1997) Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett. 116, 197-203.
40. Asawanonda, P. and Klahan, S. O. ( 2010) Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Photomed. Laser Surg. 28, 679-684.
41. Becatti, M., Prignano, F., Fiorillo, C., Pescitelli, L., Nassi, P., Lotti, T., and Taddei, N. ( 2010) The involvement of Smac/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: Protective effects of curcumin and capsaicin. Antioxid. Redox. Signal. 13, 1309-1321.
42. Heng, M. C. Y. ( 2011) Wound healing in adult skin: aiming for perfect regeneration. Int. J. Dermatol. 50, 1058-1066.
43. Bhagavathula, N., Warner, R. L., DaSilva, M., McClintock, S. D., Barron, A., Aslam, M. N., Johnson, K. J., and Varani, J. ( 2009) A combination of curcumin and ginger extract improves abrasion wound healing in corticosteroid-impaired hairless rat skin. Wound Repair Regen. 17, 360-366.
44. Sidhu, G. S., Singh, A. K., Thaloor, D., Banaudha, K. K., Patnaik, G. K., Srimal, R. C., and Maheshwari, R. K. ( 1998) Enhancement of wound healing by curcumin in animals. Wound Repair Regen. 6, 167-177.
45. Mani, H., Sidhu, G. S., Kumari, R., Gaddipati, J. P., Seth, P., and Maheshwari, R. K. ( 2002) Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing. Biofactors 16, 29-43.
46. Gopinath, D., Ahmed, M. R., Gomathi, K., Chitra, K., Sehgal, P. K., and Jayakumar, R. ( 2004) Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 25, 1911-1917.
47. Jagetia, G. C. and Rajanikant, G. K. ( 2012) Acceleration of wound repair by curcumin in the excision wound of mice exposed to different doses of fractionated γ radiation. Int. Wound J. 9, 76-92.
48. Singer, A. J., McClain, S. A., Romanov, A., Rooney, J., and Zimmerman, T. ( 2007) Curcumin reduces burn progression in rats. Acad. Emerg. Med. 14, 1125-1129.
49. Jagetia, G. C. and Rajanikant, G. K. ( 2005) Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plast. Reconstr. Surg. 115, 515-528.
50. López-Jornet, P., Camacho-Alonso, F., Jiménez-Torres, M. J., Orduña-Domingo, A., and Gómez-García, F. ( 2011) Topical curcumin for the healing of carbon dioxide laser skin wounds in mice. Photomed. Laser Surg. 29, 809-814.
51. Sidhu, G. S., Mani, H., Gaddipati, J. P., Singh, A. K., Seth, P., Banaudha, K. K., Patnaik, G. K., and Maheshwari, R. K. ( 1999) Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen. 7, 362-374.
52. Mukherjee, P. K., Maity, N., Nema, N. K., and Sarkar, B. K. ( 2011) Bioactive compounds from natural resources against skin aging. Phytomedicine 19, 64-73.
53. Lima, C. F., Pereira-Wilson, C., and Rattan, S. I. ( 2011) Curcumin induces heme oxygenase-1 in normal human skin fibroblasts through redox signaling: relevance for anti-aging intervention. Mol. Nutr. Food Res. 55, 430-442.
54. Bala, K., Tripathy, B. C., and Sharma, D. ( 2006) Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology 7, 81-89.
55. Shen, L. R., Xiao, F., Yuan, P., Chen, Y., Gao, Q. K., Parnell, L. D., Meydani, M., Ordovas, J. M., Li, D., and Lai, C. Q. ( 2012) Curcumin-supplemented diets increase superoxide dismutase activity and mean lifespan in Drosophila. Age (Dordr). 2012. [Epub ahead of print].
56. Patriarca, S., Furfaro, A. L., Cosso, L., Pesce Maineri, E., Balbis, E., Domenicotti, C., Nitti, M., Cottalasso, D., Marinari, U. M., Pronzato, M. A., and Traverso, N. ( 2007) Heme oxygenase 1 expression in rat liver during ageing and ethanol intoxication. Biogerontology 8, 365-372.
57. Schipper, H. M. ( 2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp. Gerontol. 35, 821-830.
58. Rattan, S. I. S., Fernandes, R. A., Demirovic, D., Dymek, B., and Lima, C. F. ( 2009) Heat stress and hormetin-induced hormesis in human cells: effects on aging, wound healing, angiogenesis, and differentiation. Dose Response 7, 90-103.
59. Scharstuhl, A., Mutsaers, H. A. M., Pennings, S. W. C., Szarek, W. A., Russel, F. G. M., and Wagener, F. A. D. T. G. ( 2009) Curcumin-induced fibroblast apoptosis and in vitro wound contraction are regulated by antioxidants and heme oxygenase: implications for scar formation. J. Cell. Mol. Med. 13, 712-725.
60. Zhang, D., Huang, C., Yang, C., Liu, R. J., Wang, J., Niu, J., and Bromme, D. ( 2011) Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. Respir. Res. 12, 154-154.
61. Chatterjee, S. J. and Pandey, S. ( 2011) Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy. Cancer Biol. Ther. 11, 216-228.
62. Marin, Y. E., Wall, B. A., Wang, S., Namkoong, J., Martino, J. J., Suh, J., Lee, H. J., Rabson, A. B., Yang, C. S., Chen, S., and Ryu, J.-H. ( 2007) Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res. 17, 274-283.
63. Garg, R., Ramchandani, A. G., and Maru, G. B. ( 2008) Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin. Carcinogenesis 29, 1249-1257.
64. Heng, M. C. Y. ( 2010) Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy. Int. J. Dermatol. 49, 608-622.
65. Onoue, S., Takahashi, H., Kawabata, Y., Seto, Y., Hatanaka, J., Timmermann, B., and Yamada, S. ( 2010) Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J. Pharm. Sci. 99, 1871-1881.
66. Chen, Y., Wu, Q., Zhang, Z., Yuan, L., Liu, X., and Zhou, L. ( 2012) Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17, 5972-5987.
67. Wang, H., Hu, L., Li, C., Zhang, J., and Zhang, T. ( 2011) Increase of therapeutic activity of doxorubicin by long circulating liposomes in combination with curcumin. Pharmazie 66, 871-874.
68. Wadajkar, A. S., Bhavsar, Z., Ko, C.-Y., Koppolu, B., Cui, W., Tang, L., and Nguyen, K. T. ( 2012) Multifunctional particles for melanoma-targeted drug delivery. Acta Biomater. 8, 2996-3004.
69. Koop, H. S., Da-lozzo, E. J., de Freitas, R. A., Franco, C. R. C., Mitchell, D. A., and Silveira, J. L. M. ( 2012) Rheological characterization of a xanthan-galactomannan hydrogel loaded with lipophilic substances. J. Pharm. Sci. 101, 2457-2467.
70. Mangalathillam, S., Rejinold, N. S., Nair, A., Lakshmanan, V.-K., Nair, S. V., and Jayakumar, R. ( 2012) Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 4, 239-250.
71. Ratanajiajaroen, P. and Ohshima, M. ( 2012) Synthesis, release ability and bioactivity evaluation of chitin beads incorporated with curcumin for drug delivery applications. J. Microencapsul 29:549-558.
72. Suwannateep, N., Wanichwecharungruang, S., Fluhr, J., Patzelt, A., Lademann, J., and Meinke, M. C. ( 2012) Comparison of two encapsulated curcumin particular systems contained in different formulations with regard to in vitro skin penetration. Skin. Res. Technol. doi: 10.1111/j.1600-0846.2011.00600.x. [Epub ahead of print].
73. Gupta, N. K. and Dixit, V. K. ( 2011) Development and evaluation of vesicular system for curcumin delivery. Arch. Dermatol. Res. 303, 89-101.
74. Rungphanichkul, N., Nimmannit, U., Muangsiri, W., and Rojsitthisak, P. ( 2011) Preparation of curcuminoid niosomes for enhancement of skin permeation. Pharmazie 66, 570-575.
75. Liu, C.-H. and Chang, F.-Y. ( 2011) Development and characterization of eucalyptol microemulsions for topic delivery of curcumin. Chem. Pharm. Bull. (Tokyo) 59, 172-178.
76. Liu, C.-H., Chang, F.-Y., and Hung, D.-K. ( 2011) Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf. B Biointerfaces 82, 63-70.
77. Chaudhary, H., Kohli, K., Amin, S., Rathee, P., and Kumar, V. ( 2011) Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design. J. Pharm. Sci. 100, 580-593.
78. Patel, N. A., Patel, N. J., and Patel, R. P. ( 2009) Formulation and evaluation of curcumin gel for topical application. Pharm. Dev. Technol. 14, 80-89.
79. Teichmann, A., Heuschkel, S., Jacobi, U., Presse, G., Neubert, R. H. H., Sterry, W., and Lademann, J. ( 2007) Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur. J. Pharm. Biopharm. 67, 699-706.
80. Dai, M., Zheng, X., Xu, X., Kong, X., Li, X., Guo, G., Luo, F., Zhao, X., Wei, Y. Q., and Qian, Z. ( 2009) Chitosan-alginate sponge: preparation and application in curcumin delivery for dermal wound healing in rat. J. Biomed. Biotechnol. 2009, 595126.
81. Thangapazham, R. L., Puri, A., Tele, S., Blumenthal, R., and Maheshwari, R. K. ( 2008) Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int. J. Oncol. 32, 1119-1123.
82. Swaroop, S., Mishra, B., and Priyadarsini, K. I. ( 2007) β-cyclodextrin inclusion complex of curcumin. Bhabha Atom. Res. Centre (BARC) News Lett. 285, 208-212.
83. Ghosh, M., Singh, A. T. K., Xu, W., Sulchek, T., Gordon, L. I., and Ryan, R. O. ( 2011) Curcumin nanodisks: formulation and characterization. Nanomedicine 7, 162-167.
84. Zhang, F., Koh, G. Y., Jeansonne, D. P., Hollingsworth, J., Russo, P. S., Vicente, G., Stout, R. W., and Liu, Z. ( 2011) A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity. J. Pharm. Sci. 100, 2778-2789.
85. Lambert, J. D., Hong, J., Yang, G.-Y., Liao, J., and Yang, C. S. ( 2005) Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr. 81 ( Suppl), 284-291.
86. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., Ko, J. Y., Lin, J. T., Lin, B. R., Ming-Shiang, W., Yu, H. S., Jee, S. H., Chen, G. S., Chen, T. M., Chen, C. A., Lai, M. K., Pu, Y. S., Pan, M. H., Wang, Y. J., Tsai, C. C., and Hsieh, C. Y. ( 2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21, 2895-2900.
87. Hsu, C.-H. and Cheng, A.-L. ( 2007) Clinical studies with curcumin. Adv. Exp. Med. Biol. 595, 471-480.
88. Panahi, Y., Sahebkar, A., Amiri, M., Davoudi, S. M., Beiraghdar, F., Hoseininejad, S. L., and Kolivand, M. ( 2011) Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 108, 1272-1279.